139 related articles for article (PubMed ID: 38511649)
1. Discovery of DNL343: A Potent, Selective, and Brain-Penetrant eIF2B Activator Designed for the Treatment of Neurodegenerative Diseases.
Craig RA; De Vicente J; Estrada AA; Feng JA; Lexa KW; Canet MJ; Dowdle WE; Erickson RI; Flores BN; Haddick PCG; Kane LA; Lewcock JW; Moerke NJ; Poda SB; Sweeney Z; Takahashi RH; Tong V; Wang J; Yulyaningsih E; Solanoy H; Scearce-Levie K; Sanchez PE; Tang L; Xu M; Zhang R; Osipov M
J Med Chem; 2024 Apr; 67(7):5758-5782. PubMed ID: 38511649
[TBL] [Abstract][Full Text] [Related]
2. Vanishing white matter: deregulated integrated stress response as therapy target.
Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS
Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619
[TBL] [Abstract][Full Text] [Related]
3. Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver.
Wisse LE; Visser D; Ter Braak TJ; Bakkali A; Struys EA; Morrison CD; van der Knaap MS; Abbink TEM
Nutr Neurosci; 2022 Jun; 25(6):1219-1230. PubMed ID: 33236691
[No Abstract] [Full Text] [Related]
4. eIF2B: recent structural and functional insights into a key regulator of translation.
Wortham NC; Proud CG
Biochem Soc Trans; 2015 Dec; 43(6):1234-40. PubMed ID: 26614666
[TBL] [Abstract][Full Text] [Related]
5. The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes.
Wong YL; LeBon L; Edalji R; Lim HB; Sun C; Sidrauski C
Elife; 2018 Feb; 7():. PubMed ID: 29489452
[TBL] [Abstract][Full Text] [Related]
6. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways.
Li W; Wang X; Van Der Knaap MS; Proud CG
Mol Cell Biol; 2004 Apr; 24(8):3295-306. PubMed ID: 15060152
[TBL] [Abstract][Full Text] [Related]
7. Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter disease.
Cabilly Y; Barbi M; Geva M; Marom L; Chetrit D; Ehrlich M; Elroy-Stein O
PLoS One; 2012; 7(10):e46715. PubMed ID: 23056417
[TBL] [Abstract][Full Text] [Related]
8. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease].
Kashiwagi K; Ito T; Yokoyama S
Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977
[TBL] [Abstract][Full Text] [Related]
9. Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response.
Keefe MD; Soderholm HE; Shih HY; Stevenson TJ; Glaittli KA; Bowles DM; Scholl E; Colby S; Merchant S; Hsu EW; Bonkowsky JL
Elife; 2020 Dec; 9():. PubMed ID: 33300869
[TBL] [Abstract][Full Text] [Related]
10. The Energy Status of Astrocytes Is the Achilles' Heel of eIF2B-Leukodystrophy.
Herrero M; Daw M; Atzmon A; Elroy-Stein O
Cells; 2021 Jul; 10(8):. PubMed ID: 34440627
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of Eukaryotic Initiation Factor 2B (eIF2B) Activators.
Pei Y; Liu S; Wang L; Chen C; Hu M; Xue Y; Guan D; Xie L; Liao H; Zhou J; Zhang H
ChemMedChem; 2024 Jun; 19(11):e202300716. PubMed ID: 38426720
[TBL] [Abstract][Full Text] [Related]
12. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
Pan YX; Wu Y; Niu ZP; Jiang YW
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of the integrated stress response accelerates disease progression in an amyotrophic lateral sclerosis mouse model.
Marlin E; Valencia M; Peregrín N; Ferrero R; Nicolás MJ; Vinueza-Gavilanes R; Pineda-Lucena A; Artieda J; Arrasate M; Aragón T
Br J Pharmacol; 2024 Feb; 181(3):495-508. PubMed ID: 37823684
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
[TBL] [Abstract][Full Text] [Related]
15. A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease.
de Almeida RA; Fogli A; Gaillard M; Scheper GC; Boesflug-Tanguy O; Pavitt GD
PLoS One; 2013; 8(1):e53958. PubMed ID: 23335982
[TBL] [Abstract][Full Text] [Related]
16. eIF2B activator prevents neurological defects caused by a chronic integrated stress response.
Wong YL; LeBon L; Basso AM; Kohlhaas KL; Nikkel AL; Robb HM; Donnelly-Roberts DL; Prakash J; Swensen AM; Rubinstein ND; Krishnan S; McAllister FE; Haste NV; O'Brien JJ; Roy M; Ireland A; Frost JM; Shi L; Riedmaier S; Martin K; Dart MJ; Sidrauski C
Elife; 2019 Jan; 8():. PubMed ID: 30624206
[TBL] [Abstract][Full Text] [Related]
17. Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice.
Lin Y; Pang X; Huang G; Jamison S; Fang J; Harding HP; Ron D; Lin W
J Neurosci; 2014 Sep; 34(36):12182-91. PubMed ID: 25186761
[TBL] [Abstract][Full Text] [Related]
18. Human-induced pluripotent stem cell-derived cerebral organoid of leukoencephalopathy with vanishing white matter.
Deng J; Zhang J; Gao K; Zhou L; Jiang Y; Wang J; Wu Y
CNS Neurosci Ther; 2023 Apr; 29(4):1049-1066. PubMed ID: 36650674
[TBL] [Abstract][Full Text] [Related]
19. Adult mouse eIF2Bε Arg191His astrocytes display a normal integrated stress response in vitro.
Wisse LE; Ter Braak TJ; van de Beek MC; van Berkel CGM; Wortel J; Heine VM; Proud CG; van der Knaap MS; Abbink TEM
Sci Rep; 2018 Feb; 8(1):3773. PubMed ID: 29491431
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells.
Sekine Y; Zyryanova A; Crespillo-Casado A; Amin-Wetzel N; Harding HP; Ron D
PLoS One; 2016; 11(11):e0166278. PubMed ID: 27812215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
